Timur R Nizamov

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 10

Top Topics

Molecularly Imprinted

Top Venues

Materials (Basel, Switzerland)

Nanomaterials (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Timur R Nizamov, Abdulkarim A Amirov, Tatiana O Kuznetsova, Irina V Dorofievich, Igor G Bordyuzhin, Dmitry G Zhukov, Anna V Ivanova, Anna N Gabashvili, Constantine Likhnitskii, Alexander A Tepanov, Igor V Shchetinin, Maxim A Abakumov, Alexander G Savchenko, Alexander G Majouga
Synthesis and Functional Characterization of Co x Fe 3-x O 4 -BaTiO 3 Magnetoelectric Nanocomposites for Biomedical Applications. Nanomaterials (Basel, Switzerland) 13 (5) (2023)
Timur R Nizamov, Abdulkarim A Amirov, Tatiana O Kuznetsova, Irina V Dorofievich, Igor G Bordyuzhin, Dmitry G Zhukov, Anna V Ivanova, Anna N Gabashvili, Constantine Likhnitskii, Alexander A Tepanov, Igor V Shchetinin, Maxim A Abakumov, Alexander G Savchenko, Alexander G Majouga
Synthesis and Functional Characterization of Co x Fe 3-x O 4 -BaTiO 3 Magnetoelectric Nanocomposites for Biomedical Applications. Nanomaterials (Basel, Switzerland) 13 (5) (2023)
Timur R Nizamov, Abdulkarim A Amirov, Tatiana O Kuznetsova, Irina V Dorofievich, Igor G Bordyuzhin, Dmitry G Zhukov, Anna V Ivanova, Anna N Gabashvili, Constantine Likhnitskii, Alexander A Tepanov, Igor V Shchetinin, Maxim A Abakumov, Alexander G Savchenko, Alexander G Majouga
Synthesis and Functional Characterization of Co x Fe 3-x O 4 -BaTiO 3 Magnetoelectric Nanocomposites for Biomedical Applications. Nanomaterials (Basel, Switzerland) 13 (5) (2023)
Timur R Nizamov, Artem R Iliasov, Stepan Sergeevich Vodopyanov, Irina V Kozhina, Igor G Bordyuzhin, Dmitry G Zhukov, Anna V Ivanova, Elizaveta S Permyakova, Pavel S Mogilnikov, Daniil A Vishnevskiy, Igor V Shchetinin, Maxim A Abakumov, Alexander G Savchenko
Study of Cytotoxicity and Internalization of Redox-Responsive Iron Oxide Nanoparticles on PC-3 and 4T1 Cancer Cell Lines. Pharmaceutics 15 (1) (2022)
Polina I Nikolenko, Timur R Nizamov, Igor G Bordyuzhin, Maxim A Abakumov, Yulia A Baranova, Alexander D Kovalev, Igor V Shchetinin
Structure and Magnetic Properties of SrFe 12-x In x O 19 Compounds for Magnetic Hyperthermia Applications. Materials (Basel, Switzerland) 16 (1) (2022)
Polina I Nikolenko, Timur R Nizamov, Igor G Bordyuzhin, Maxim A Abakumov, Yulia A Baranova, Alexander D Kovalev, Igor V Shchetinin
Structure and Magnetic Properties of SrFe 12-x In x O 19 Compounds for Magnetic Hyperthermia Applications. Materials (Basel, Switzerland) 16 (1) (2022)
Timur R Nizamov, Artem R Iliasov, Stepan Sergeevich Vodopyanov, Irina V Kozhina, Igor G Bordyuzhin, Dmitry G Zhukov, Anna V Ivanova, Elizaveta S Permyakova, Pavel S Mogilnikov, Daniil A Vishnevskiy, Igor V Shchetinin, Maxim A Abakumov, Alexander G Savchenko
Study of Cytotoxicity and Internalization of Redox-Responsive Iron Oxide Nanoparticles on PC-3 and 4T1 Cancer Cell Lines. Pharmaceutics 15 (1) (2022)
Timur R Nizamov, Artem R Iliasov, Stepan Sergeevich Vodopyanov, Irina V Kozhina, Igor G Bordyuzhin, Dmitry G Zhukov, Anna V Ivanova, Elizaveta S Permyakova, Pavel S Mogilnikov, Daniil A Vishnevskiy, Igor V Shchetinin, Maxim A Abakumov, Alexander G Savchenko
Study of Cytotoxicity and Internalization of Redox-Responsive Iron Oxide Nanoparticles on PC-3 and 4T1 Cancer Cell Lines. Pharmaceutics 15 (1) (2022)
Polina I Nikolenko, Timur R Nizamov, Igor G Bordyuzhin, Maxim A Abakumov, Yulia A Baranova, Alexander D Kovalev, Igor V Shchetinin
Structure and Magnetic Properties of SrFe 12-x In x O 19 Compounds for Magnetic Hyperthermia Applications. Materials (Basel, Switzerland) 16 (1) (2022)
Timur R Nizamov, Artem R Iliasov, Stepan Sergeevich Vodopyanov, Irina V Kozhina, Igor G Bordyuzhin, Dmitry G Zhukov, Anna V Ivanova, Elizaveta S Permyakova, Pavel S Mogilnikov, Daniil A Vishnevskiy, Igor V Shchetinin, Maxim A Abakumov, Alexander G Savchenko
Study of Cytotoxicity and Internalization of Redox-Responsive Iron Oxide Nanoparticles on PC-3 and 4T1 Cancer Cell Lines. Pharmaceutics 15 (1) (2022)